News

Find News

Filter articles

Showing 3091 to 3100 of 3151 results

Generics swoop as Viagra patent expires

EU24-06-2013

Global drug companies Actavis and Teva both launched generic versions of Viagra immediately after its patent expired in several European countries last week.

Federal Circuit holds Novo Nordisk patent invalid

US21-06-2013Legal developments

The US Court of Appeals for the Federal Circuit concluded on June 18 that Novo Nordisk’s patent covering diabetes treatment repaglinide is invalid.

European Commission targets alleged ‘pay-for-delay’ with pharma fines

EU20-06-2013

The European Commission’s competition directorate has levied fines totalling €146 million ($195 million) against originator pharmaceutical company Lundbeck and several producers of generics drugs.

US Supreme Court backs ‘rule-of-reason’ for pay-for-delay

US17-06-2013

A majority of the US Supreme Court has ruled that the US Federal Trade Commission should be able to challenge so-called ‘pay-for-delay’ patent litigation settlements on antitrust grounds.

Teva and Sun stung by $2 billion settlement

US14-06-2013

Generic drug-makers Teva Pharmaceutical and Sun Pharmaceutical have agreed to pay a combined $2.15 billion to settle a patent infringement case over Pfizer’s heartburn drug Protonix.

US Supreme Court strikes Myriad blow

US13-06-2013

The US Supreme Court has ruled that isolated human DNA is not patent eligible and has struck down patents owned by biotech company Myriad, ending a long-running and controversial case.

IPAB sets aside Sutent patent rejection

India07-06-2013

India’s Intellectual Property Appellate Board has set aside a decision revoking a Pfizer-licensed patent directed to cancer drug Sutent.

Shire settles with Teva over ADHD drug

US04-06-2013

Drug-maker Teva must wait until 2015 before selling generic versions of Shire’s Intuniv product, according to a patent settlement between the companies.

Takeda sues generics over heartburn drug

US31-05-2013

Japanese pharma company Takeda has sued generic drug-makers Impax and Sandoz for allegedly infringing a patent directed to its anti-heartburn drug Dexilant.

Amgen and Astellas join forces in Japan

Japan, US30-05-2013

California-based biotechnology company Amgen has entered into a long-term partnership with Japanese pharmaceutical company Astellas Pharmas Inc to provide new medicines in Japan.

Showing 3091 to 3100 of 3151 results

LSIPR